Does the Ukrain preparation protect mice against lethal doses of bacteria?

Drugs under Experimental and Clinical Research

Volumn 22, Issue 3-5, 1996, Pages 207-211

  Ciebiada, I ^a   Korczak, E ^a   Nowicky, J W ^b   Denys, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Ukrainian Anti Cancer Institute   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

UKRAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; INFLUENZA VIRUS; LD 50; MALE; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

ALKALOIDS; ANIMALS; ANTI-BACTERIAL AGENTS; BERBERINE ALKALOIDS; ESCHERICHIA COLI INFECTIONS; MICE; MICE, INBRED BALB C; PHENANTHRIDINES; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS;

EID: 0029810539     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ciebiada I., Korczak E., Denys A., Nowicky J. W. Effect of the Ukrain preparate upon the immune response in influenza virus infected mice. Proc. 9th Mediterranean Congress of Chemotherapy, Milano, 1994, abstr. 36.
2. Danysz A., Kokoschnegg M., Hamler F. Clinical studies of Ukrain in healthy volunteers (phase I). Drugs Exptl. Clin Res., XVIII (Suppl.), 39, 1992.
3. Kamyshentsev M.V. et al. Testing Ukrain as an anti-influenza remedy. Proc. 18th International Congress of Chemotherapy, Stockholm, 1993, abstr. 645.
4. Liepins A., Nowicky J.W. Activation of spleen cells' lytic activity by the alkaloid thiophosphoric acid derivative Ukrain. Int. J. Immunopharmac., 14, 1437, 1992.
5. Liepins A., Nowicky J.W. Ukrain is selectively cytostatic and/or cytotoxic to human tumor and HIV-infected cells but not to human normal cells. Proc. 17th International Congress of Chemotherapy, Berlin, 1991, abstr. 1620.
6. Liepins A., Sotomayor E.M., Lopez D.M, Nowicky J.W. Biological response modifying properties of the alkaloid derivative Ukrain (NSC 631570). Proc. 18th International Congress of Chemotherapy, Stockholm, 1993, abstr. 1138.
7. Musianowicz J. et al. Clinical studies of Ukrain in terminal cancer patients (phase II). Drugs Exptl. Clin. Res., XVIII (Suppl.), 45, 1992.
8. Nowicky J.W., Greif M., Hamler F., Hiesmayr W., Staub W. Biological activity of Ukrain in vitro and in vivo. Chemioterapia (Suppl. 2), 6, 683, 1992.
9. Nowicky J.W., Monolakis G., Meijer D., Vatanasapt V., Brzosko W.J. Ukrain both as an anti cancer and immunoregulatory agent. Drugs Exptl. Clin. Res., XVIII (Suppl.), 51, 1992.
10. Nowicky J.W., Nowicky W., Hiesmayr W. Cytostatic and cytotoxic effect of Ukrain on malignant cells. Proc. IVth Mediterranean Congress of Chemotherapy, Athens, 1992. J. Chemother., 5 (Suppl. 1), 797, 1993.
11. Nowicky J.W. et al. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L (Ukrain) as an immunostimulant in patients with various carcinomas. Drugs Exptl. Clin. Res., XVII (Suppl.), 139, 1991.
12. Sotomayor E.M., Rao K., Lopez D.M., Liepins A. Enhancement of macrophage tumoricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies. Drugs Exptl. Clin. Res., XVIII (Suppl.), 5, 1992.
13. Voltchek I.V. et al. Some immunohaematological effects of Ukrain Proc. 18th International Congress of Chemotherapy, Stockholm, 1993, abstr. 1542.
14. Zemskov V.S. et al. Experience of the application of Ukrain in oncological pratice in Ukraine. Proc. 18th International Congress of Chemotherapy, Stockholm, 1993, abstr. 731.